Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Biosym A/S
A/S
Active
Advertising protection
CVR 21774189
Lene Haus Vej 25, 7430
Ikast
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1999 · 27 years old
17 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Biosym A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
30M
23M
15M
8M
0M
19M
2021
13M
-32%
2022
15M
+15%
2023
16M
+7%
2024
24M
+50%
2025
EBITDA
DKK millions
15M
11M
8M
4M
0M
10M
2021
4M
-60%
2022
6M
+50%
2023
6M
0%
2024
12M
+100%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
18.635
12.991
15.335
16.196
23.553
Staff expenses
-8.237
-8.789
-9.274
-10.322
-11.658
EBITDA
10.376
4.202
6.062
5.874
11.894
Depreciation & amort.
-847
-794
-573
-428
-464
EBIT
9.530
3.408
5.489
5.446
11.430
Net financials
-417
-735
-914
-553
-492
Profit before tax
9.113
2.673
4.575
4.893
10.938
Tax
2.005
563
463
1.082
2.408
Net profit
7.108
2.110
4.112
3.811
8.530
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
55.319
71.573
57.826
58.197
72.550
Equity
27.749
29.859
33.970
37.781
46.312
Long-term debt
9.176
16.336
12.941
8.917
4.798
Short-term debt
18.394
25.378
10.915
11.500
21.440
Total debt
27.570
41.714
23.855
20.416
26.238
Financial ratios
5-year trend
EBITDA margin (of gross profit)
50.5%
This company
2021
2025
Equity ratio
63.8%
This company
38.2%
Market median
67% above market
2021
2025
Return on equity
18.4%
This company
18.4%
Market median
0% above market
2021
2025
Net profit margin (of gross profit)
36.2%
This company
2021
2025
Asset turnover (of gross profit)
0.32×
This company
2021
2025
Debt / equity
0.57×
This company
0.62×
Market median
8% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Biosym A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
